Rakovina Therapeutics: Top 10 Undervalued Biotechnology Industry Stocks (RKV)
Rakovina Therapeutics is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| QPT | Quest PharmaTech | 0.04 | 0.12 | 0.08 (229.5%) | 11830 | 5.9 | 0.0 | 0.0 |
| KNE | Kane Biotech | 0.05 | 0.09 | 0.04 (83.9%) | 152309 | 6.7 | 0.0 | 0.0 |
| RVX | Resverlogix | 0.04 | 0.08 | 0.03 (74.7%) | 40040 | 12.7 | 0.0 | 0.0 |
| MBX | Microbix Biosystems | 0.34 | 0.58 | 0.24 (70.5%) | 65504 | 47.8 | 0.0 | 30.9 |
| GSD | Devonian Health Gr | 0.17 | 0.28 | 0.11 (66.2%) | 3223 | 25.2 | 0.0 | 0.0 |
| VXL | Vaxil Bio | 0.23 | 0.37 | 0.14 (61.9%) | 2610 | 0.6 | 0.0 | 0.0 |
| MDNA | Medicenna Therapeutics | 0.95 | 1.47 | 0.52 (54.6%) | 35801 | 74.1 | 0.0 | 0.0 |
| MRVL | Marvel Biosciences | 0.10 | 0.16 | 0.05 (49.4%) | 34778 | 4.7 | 0.0 | 0.0 |
| CSCI | Cosciens Biopharma | 4.80 | 7.10 | 2.30 (48.0%) | 1603 | 15.1 | 0.0 | 0.0 |
| RKV | Rakovina Therapeutics | 0.06 | 0.08 | 0.02 (44.1%) | 542191 | 4.5 | 0.0 | 0.0 |
All data provided as of July 13, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Rakovina Therapeutics
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before.
Rakovina Therapeutics is listed under RKV on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
